Literature DB >> 2787345

Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.

M J Klemsz1, L B Justement, E Palmer, J C Cambier.   

Abstract

The data presented here indicated that both membrane Ig and IL-4 receptors transduce signals across the plasma membrane of quiescent B cells, which results in the induction of c-fos and c-myc proto-oncogene mRNA expression. Monoclonal anti-Ig antibodies with specificity for mu, delta, or kappa chains, regardless of mitogenicity, induced increased c-fos and c-myc mRNA expression with kinetics and magnitude similar to that observed following stimulation of B cells with IL-4. Maximal levels of c-fos mRNA, approximately 30-fold over background, were observed 30 min after stimulation. Maximal levels of c-myc mRNA, approximately 10-fold over background, were observed 60 min after stimulation. Phorbol myristate acetate alone induced expression of these two oncogenes in a similar fashion, suggesting that protein kinase C may be involved in the regulation of their expression following anti-Ig crosslinking. Ionomycin induced only a small increase in c-myc and c-fos message (three- to four-fold), and did not synergize with phorbol myristate acetate, suggesting that the membrane Ig-mediated calcium mobilization may not play a major role in regulation of c-myc or c-fos expression in mouse B cells. In vitro nuclear run-on analyses indicate that c-myc expression is primarily regulated post-transcriptionally, whereas c-fos expression is regulated at the level of transcription. Anti-sense transcription was found to be constitutive for both the c-myc and C-fos loci and was further induced by anti-Ig and IL-4, suggesting an additional mechanism for regulation of these genes. The observation that both anti-Ig and IL-4 regulate the expression of c-fos and c-myc suggests that multiple second messenger generating systems regulate the expression of these oncogenes in normal B cells and that their expression may be necessary, but is not sufficient to drive quiescent B cells into cell cycle.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787345

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1.

Authors:  Brian M Iritani; Jeffrey Delrow; Carla Grandori; Ivan Gomez; Meredith Klacking; Leni Sue Carlos; Robert N Eisenman
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

Review 2.  Transcriptional mechanisms regulating Ca(2+) homeostasis.

Authors:  Michael F Ritchie; Yandong Zhou; Jonathan Soboloff
Journal:  Cell Calcium       Date:  2010-11-13       Impact factor: 6.817

Review 3.  Signalling mechanisms underlying subversion of the immune response by the filarial nematode secreted product ES-62.

Authors:  Helen S Goodridge; Gillian Stepek; William Harnett; Margaret M Harnett
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

4.  Polarized expression of cytokines in cell conjugates of helper T cells and splenic B cells.

Authors:  A Kupfer; T R Mosmann; H Kupfer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

5.  Role of EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes.

Authors:  J S Maltzman; J A Carman; J G Monroe
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

6.  c-Myc mediates pre-TCR-induced proliferation but not developmental progression.

Authors:  Marei Dose; Irum Khan; Zhuyan Guo; Damian Kovalovsky; Andreas Krueger; Harald von Boehmer; Khashayarsha Khazaie; Fotini Gounari
Journal:  Blood       Date:  2006-06-20       Impact factor: 22.113

7.  Interleukin 4 signals through two related pathways.

Authors:  A Pernis; B Witthuhn; A D Keegan; K Nelms; E Garfein; J N Ihle; W E Paul; J H Pierce; P Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Regulation of primary response genes in B cells.

Authors:  Trent Fowler; Hyunsuk Suh; Stephen Buratowski; Ananda L Roy
Journal:  J Biol Chem       Date:  2013-03-27       Impact factor: 5.157

9.  Global regulation of promoter melting in naive lymphocytes.

Authors:  Fedor Kouzine; Damian Wojtowicz; Arito Yamane; Wolfgang Resch; Kyong-Rim Kieffer-Kwon; Russell Bandle; Steevenson Nelson; Hirotaka Nakahashi; Parirokh Awasthi; Lionel Feigenbaum; Herve Menoni; Jan Hoeijmakers; Wim Vermeulen; Hui Ge; Teresa M Przytycka; David Levens; Rafael Casellas
Journal:  Cell       Date:  2013-05-23       Impact factor: 41.582

Review 10.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.